403 related articles for article (PubMed ID: 11045115)
21. Comparative in vitro activity of cefepime against nosocomial isolates.
Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
[TBL] [Abstract][Full Text] [Related]
22. [The drug resistance of pathogenic bacteria of nosocomial infections in surgical intensive care unit].
Chen J; Li LF; Guan XD; Chen DM; Chen MY; Ouyang B; Huang SW; Wu JF
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1189-92. PubMed ID: 17147864
[TBL] [Abstract][Full Text] [Related]
23. Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting.
Nicoletti G; Schito G; Fadda G; Boros S; Nicolosi D; Marchese A; Spanu T; Pantosti A; Monaco M; Rezza G; Cassone A; Garaci E;
J Chemother; 2006 Dec; 18(6):589-602. PubMed ID: 17267336
[TBL] [Abstract][Full Text] [Related]
24. Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria.
Strateva T; Ouzounova-Raykova V; Markova B; Todorova A; Marteva-Proevska Y; Mitov I
J Chemother; 2007 Apr; 19(2):140-5. PubMed ID: 17434821
[TBL] [Abstract][Full Text] [Related]
25. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
26. Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group.
Bantar C; Famiglietti A; Goldberg M
Int J Infect Dis; 2000; 4(2):85-90. PubMed ID: 10737844
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of drug resistance spectrum and its mechanism in 1017 clinical bacterial isolates].
Geng SN; Rui YY; Wang Q; Mou CH; Zhou XH; Zhang J
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1529-32, 1545. PubMed ID: 16361155
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study).
Jarlier V; Fosse T; Philippon A
Intensive Care Med; 1996 Oct; 22(10):1057-65. PubMed ID: 8923070
[TBL] [Abstract][Full Text] [Related]
29. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group].
Oguri T; Igari J; Hiramatsu K; Watanabe A; Inoue M; Abe M; Yamane N; Aihara M; Hashimoto H;
Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups.
Hanberger H; Garcia-Rodriguez JA; Gobernado M; Goossens H; Nilsson LE; Struelens MJ
JAMA; 1999 Jan; 281(1):67-71. PubMed ID: 9892453
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
32. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan.
Hsueh PR; Liu YC; Yang D; Yan JJ; Wu TL; Huang WK; Wu JJ; Ko WC; Leu HS; Yu CR; Luh KT
Microb Drug Resist; 2001; 7(4):373-82. PubMed ID: 11822777
[TBL] [Abstract][Full Text] [Related]
33. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
34. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
Van Eldere J
J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
[TBL] [Abstract][Full Text] [Related]
35. Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000.
Friedland I; Stinson L; Ikaiddi M; Harm S; Woods GL
Infect Control Hosp Epidemiol; 2003 Aug; 24(8):607-12. PubMed ID: 12940583
[TBL] [Abstract][Full Text] [Related]
36. In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates.
Cormican M; Corbett-Feeney G; Kelly S; Hughes D; Flynn J; Jones RN
Ir J Med Sci; 1998; 167(3):155-9. PubMed ID: 9780564
[TBL] [Abstract][Full Text] [Related]
37. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey.
Decousser JW; Pina P; Picot F; Delalande C; Pangon B; Courvalin P; Allouch P;
J Antimicrob Chemother; 2003 May; 51(5):1213-22. PubMed ID: 12697655
[TBL] [Abstract][Full Text] [Related]
38. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
DeRyke CA; Kuti JL; Nicolau DP
Pharmacotherapy; 2007 Mar; 27(3):333-42. PubMed ID: 17316145
[TBL] [Abstract][Full Text] [Related]
40. [Antibiotic sensitivity of enterobacteria in intensive care units].
Pina P; Pangon B; Rio Y; Chardon H; Lallali AK; Allouch PY
Pathol Biol (Paris); 2000 Jun; 48(5):485-9. PubMed ID: 10949846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
